1. USD

    82.09

    Today's change

    0.11 / +0.13%

    1 year change

    -3.10%

    As of Jul 26 2016 21:00 BST. Data delayed by at least 15 minutes.

Search for Eli Lilly & Co and
  1. Fast FT

    May 17, 2016

    Epstein out as Novartis splits cancer from pharma unit

    Swiss pharmaceuticals group Novartis announced on Tuesday plans to separate its oncology unit from its pharmaceuticals...

  2. May 16, 2016

    Biotech groups sink their teeth into the Big Apple

    When Cellectis, a French biotech group, opened a US subsidiary last year, it dispensed with tradition and picked an...

Special Reports

  1. Combating Diabetes

    Urbanisation, poor diet and failure to exercise have led to record levels of obesity, ...
  2. Special Report: Boldness in Business 2012

    Seven success stories are honoured in this year’s awards...
Search more Special Reports on this topic.

  1. Fast FT

    April 26, 2016

    Eli Lilly takes $200m charge due to Venezuelan crisis

    The Venezuelan financial crisis prompted Eli Lilly, the US drugmaker, to take a $200m charge in the first quarter, as...

  2. April 26, 2016

    Tony Coles – on a mission to tackle Alzheimer’s

    After brokering the $10bn sale of the biotech company he led, Tony Coles planned to follow the well-trodden path of...

  3. April 3, 2016

    Drugmakers race to prescribe preventive migraine remedies

    Migraines are one of the most common illnesses worldwide, affecting about 1 in 7 people and more than 30m in the US...

  4. March 29, 2016

    Chi-Med taps Nasdaq for $100m to help break innovation drought

    A $100m Nasdaq flotation has given a fresh impetus to efforts by Hutchison China MediTech to produce the first drug to...

  5. Fast FT

    March 4, 2016

    Novo Nordisk diabetes drug cuts heart risk, trial shows

    Shares in Novo Nordisk are up more than 8 per cent after the Danish drugmaker said results from a major trial showed...

  6. Fast FT

    January 28, 2016

    Healthcare, biotech stocks slammed

    It’s another brutal day for healthcare and biotech stocks, which have been prone to big sell-offs ever since Hillary...

  7. January 25, 2016

    Brexit would be a ‘mistake’, say global pharma leaders

    A British exit from the EU would isolate the country’s scientists and reduce its influence in medicine, global...

  8. January 18, 2016

    Pharma sell-off threatens to stifle appetite for IPOs

    After months of battling a public outcry over high drug prices, the pharmaceuticals and biotech industry had hoped that...

  9. Fast FT

    January 5, 2016

    Eli Lilly shares dip pre-market after fresh forecasts

    Eli Lilly, the US drugmaker that has steered clear of the frenzy of dealmaking sweeping the pharmaceutical industry,...

  10. December 30, 2015

    China Animal Healthcare document loss highlights investor risks

    In the litany of accounting problems emerging at Chinese companies, Hong Kong-listed China Animal Healthcare has...

  11. December 15, 2015

    Sanofi/Boehringer: swap shop

    Swapping assets was a form of human trade since long before bankers and their fees arrived on the scene. In...

  12. December 15, 2015

    Sanofi seeks to expand in consumer health with €18bn asset swap

    Sanofi has entered exclusive talks with Boehringer Ingelheim over an €18bn asset exchange that would see the French...

  13. December 1, 2015

    Eli Lilly and Merck bolstered by upgrades

    Pharmaceutical stocks received a shot in the arm after analysts at Barclays upgraded Eli Lilly and Merck citing...

  14. November 13, 2015

    Animal health: double or quits

    Sea lice. Fowl pox. Swine fever. Foot-and-mouth. Animal diseases often take prosaic names. This does not make them...

  15. October 21, 2015

    Pharma groups join UK in $100m dementia fund

    A $100m dementia research fund has been launched with backing from the British government and several of the world’s...

  16. October 18, 2015

    Weekahead: Corporate diary

    Diary commentary from FT reporters; data and company announcements, unless otherwise stated, from Thomson Reuters....

  17. October 12, 2015

    Eli Lilly’s heart-drug setback reverberates through pharma sector

    Shares of several of the US’s largest drugmakers were roiled on Monday after Eli Lilly surprisingly halted development...

  18. October 12, 2015

    Eli Lilly shares sink as it scraps heart drug

    Eli Lilly has pulled the plug on a potential blockbuster medicine intended to ward off heart attacks and strokes,...

  19. October 6, 2015

    Axovant seeks first approval for an Alzheimer’s drug in a decade

    A company that completed the largest ever biotech listing earlier this year has started testing its Alzheimer’s...

  20. October 6, 2015

    Bristol-Myers to pay SEC $14m to settle China bribery claim

    US drugmaker Bristol-Myers Squibb is to pay $14m in penalties to US authorities over alleged “improper payments” made...

  21. September 24, 2015

    Eli Lilly set for diabetes drug boost

    When Eli Lilly and Boehringer Ingelheim unveiled the results of a study into Jardiance, their diabetes drug, at a...

  22. July 24, 2015

    Week in Review, July 25

    A round up of some of the week’s most significant corporate events and news stories. Credit Suisse soars on back of...

  23. July 22, 2015

    Eli Lilly: think it through

    The search for a cure for the degenerative disease Alzheimer’s has been long and hard. Billions have been spent....

  24. July 22, 2015

    Alzheimer’s breakthrough hopes add to promise of pharma revival

    Hopes of a breakthrough against Alzheimer’s disease have been boosted by encouraging clinical trial data from Eli Lilly...

  25. July 22, 2015

    Eli Lilly raises hopes for breakthrough Alzheimer’s drug

    Eli Lilly has raised hopes for a breakthrough in the treatment of Alzheimer’s disease after unveiling evidence that its...

  26. July 19, 2015

    Pharmaceuticals: Brain power

    Garbed in white lab coat and goggles, a young scientist carefully cuts a mouse’s brain into wafer thin slices. She adds...

  27. July 17, 2015

    Cautionary tale as Receptos benefits from buying frenzy

    If you can’t beat ’em, buy ’em. That seems to be the mantra this week after Celgene agreed to pay $7.2bn for the maker...

  28. July 16, 2015

    Immunocore in record European biotech raising

    Immunocore, the Oxford-based cancer drug developer, has secured $320m in the biggest private fundraising by a European...

  29. July 1, 2015

    Pharma groups eye healthy returns from animal drugs market

    A treatment for dogs with itchy skin has turned out to be something of a tonic for investors. Apoquel launched last...

  30. June 29, 2015

    Eli Lilly and Immunocore in cocktail collaboration against cancer

    Eli Lilly of the US is to expand its alliance with Immunocore of the UK in the latest example of pharmaceuticals...

  31. June 25, 2015

    Johnson floats £10bn biotech fund for London

    Plans for a £10bn fund to boost investment in life sciences have been floated by Boris Johnson, London mayor, as part...

  32. April 29, 2015

    Takeda to pay $2.7bn to settle Actos cancer claims

    In one of the largest product liability settlements to date, Takeda Pharmaceutical has agreed to pay $2.7bn over claims...

  33. April 5, 2015

    UK reprieve for three cancer drugs

    Three cancer drugs that were supposed to be removed from the National Health Service on cost grounds have been granted...

  34. March 27, 2015

    Insulin: moving the needle

    It has been a sweet run. The biggest companies in the insulin business — Sanofi, Novo Nordisk, and Eli Lilly — have...

  35. March 26, 2015

    Indiana signs ‘religious freedom’ bill

    Indiana Governor Mike Pence has signed a bill that would allow businesses to refuse service to gay and lesbian patrons...

  36. March 20, 2015

    Biogen’s Alzheimer’s drug shows early promise

    An experimental Alzheimer’s drug being developed by a US biotech group has offered hope that scientists may be closer...

  37. March 17, 2015

    Dementia research boosted by $100m venture capital fund

    Research into dementia is to be boosted by a $100m venture capital fund backed by the UK government and several of the...

  38. February 24, 2015

    Eli Lilly stays out of deals fray as it eyes ‘moon shot’ drugs

    The pharmaceutical industry is gripped by deals fever, but one company is conspicuously absent from the lists of...

Search for Eli Lilly & Co and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. Lex on whether 26% share climb is overly optimistic...
    July 22, 2015

    Lex on whether 26% share climb is overly optimistic

  2. Eli Lilly's John Lechleiter says pharma must reach out to inn...
    June 15, 2012

    Eli Lilly's John Lechleiter says pharma must reach out ...